NovaBio Sciences · 2,400 employees · North-star: 75% strategy recall
| Department | Tickets | Δ |
|---|---|---|
| Engineering | 18 | -8 |
| Product | 11 | -5 |
| Sales | 9 | -3 |
| Marketing | 7 | -2 |
| Operations | 12 | +1 |
| R&D | 6 | -4 |
| Total | 63 | -21 |
| Region | Reach % | Recall % | Trust % |
|---|---|---|---|
| North America | 84% | 72% | 75% |
| EMEA | 79% | 68% | 71% |
| APAC | 77% | 65% | 68% |
| LATAM | 73% | 61% | 64% |
| Global Avg | 81% | 69% | 72% |